4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0000950170-25-013752
Options or other derivatives
- Chief Scientific Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bredt David Chief Scientific Officer | 2025-02-03 | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | D | ||
Loading xslF345X05/ownership.xml…